Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

541.89
+60.4212.55%
Pre-market: 550.808.91+1.64%08:36 EDT
Volume:3.34M
Turnover:1.79B
Market Cap:23.24B
PE:19.39
High:557.37
Open:482.20
Low:475.46
Close:481.47
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:6.52
T/O Rate:8.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.63
PE(LYR):19.45

Loading ...

United Therapeutics Advances High-Risk, High-Reward Xenokidney Trial for ESRD

TIPRANKS
·
May 28

United Therapeutics CFO James Edgemond presents at Jefferies Global Healthcare Conference

Reuters
·
May 27

United Therapeutics CEO Martine Rothblatt sells common shares worth $5.37 million

Reuters
·
May 27

Assessing United Therapeutics (UTHR) Valuation After Strong Recent Shareholder Returns

Simply Wall St.
·
May 26

United Therapeutics CFO James Edgemond disposes of shares worth $5.64 million

Reuters
·
May 23

United Therapeutics CEO Martine Rothblatt sells USD 5.36 million in common stock

Reuters
·
May 23

United Therapeutics CEO Martine Rothblatt disposes of USD 4.55 million in shares

Reuters
·
May 22

United Therapeutics EVP, General Counsel Paul Mahon disposes 8,300 shares for $4.67 million

Reuters
·
May 22

United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.39 million

Reuters
·
May 21

J.P. Morgan Keeps Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
May 20

United Therapeutics Corp : JP Morgan Resumes Coverage With Overweight Rating; Price Target $685

THOMSON REUTERS
·
May 20

United Therapeutics CFO James Edgemond disposes of USD 5.64 million common shares

Reuters
·
May 20

Jefferies Remains a Buy on United Therapeutics (UTHR)

TIPRANKS
·
May 19

United Therapeutics CEO Martine Rothblatt disposes of common shares worth $5.39 million

Reuters
·
May 19

United Therapeutics says TETON-1 study published in NEJM

TIPRANKS
·
May 19

United Therapeutics says Tyvaso meets primary endpoint in TETON-1 IPF trial

Reuters
·
May 19

United Therapeutics Says Pulmonary Arterial Hypertension Treatment Meets Primary Endpoint in Late-Stage Trial

MT Newswires Live
·
May 18

Baidu, Brady And 3 Stocks To Watch Heading Into Monday

Benzinga Earnings
·
May 18

TD Cowen Reaffirms Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
May 18

BRIEF-United Therapeutics Announces Advance Outcomes Study Of Ralinepag

Reuters
·
May 18